Skip to main content
. 2010 Sep;161(3):512–517. doi: 10.1111/j.1365-2249.2010.04187.x

Table 2.

Secondary efficacy parameters.

Secondary parameter Days/patients Mean days per patient Mean proportion
Antibiotic use (with prophylaxis) 3792/46 4·35 ± 105·10 20·56 ± 29·05%
Antibiotic use (without prophylaxis) 1638/44 32·12 ± 47·17 9·03 ± 13·25%
ARIs (respiratory) 2026/40 39·73 ± 50·58 11·28 ± 14·71%
ARIs (other) 344/17 6·75 ± 16·33 1·82 ± 4·24%
Fever (>38°C) 91/21 1·78 ± 3·09 0·50 ± 0·88%
School/work absence 200/23 3·92 ± 7·04 1·12 ± 2·02%
Hospitalization (days for treatment of infection) 18/3 0·35 ± 1·47 0·10 ± 0·40%

ARI, acute and relevant infection.